EstechPharma Co. Ltd (041910) — Cash Flow-to-Debt Ratio
EstechPharma Co. Ltd (041910) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩2.38 Billion could theoretically repay 0% of its total liabilities (₩60.00 Billion) in one year. See financial agility of EstechPharma Co. Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
EstechPharma Co. Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for EstechPharma Co. Ltd across 13 annual periods. For the full cash flow conversion analysis, see 041910 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for EstechPharma Co. Ltd (2013–2025)
Year-by-year debt coverage analysis for EstechPharma Co. Ltd. Check how high is EstechPharma Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | ₩8.83 Billion | ₩60.00 Billion | ▼ -89.1% |
| 2024 | 1.35x | ₩7.93 Billion | ₩5.87 Billion | ▲ +76.9% |
| 2023 | 0.76x | ₩4.79 Billion | ₩6.27 Billion | ▲ +481.2% |
| 2022 | -0.20x | ₩-1.65 Billion | ₩8.23 Billion | ▼ -467.5% |
| 2021 | 0.05x | ₩603.42 Million | ₩11.06 Billion | ▼ -86.4% |
| 2020 | 0.40x | ₩4.71 Billion | ₩11.76 Billion | ▲ +28.0% |
| 2019 | 0.31x | ₩4.29 Billion | ₩13.71 Billion | ▼ -60.7% |
| 2018 | 0.80x | ₩7.25 Billion | ₩9.09 Billion | ▲ +43.4% |
| 2017 | 0.56x | ₩6.99 Billion | ₩12.57 Billion | ▲ +36.2% |
| 2016 | 0.41x | ₩8.19 Billion | ₩20.05 Billion | ▼ -24.9% |
| 2015 | 0.54x | ₩10.46 Billion | ₩19.24 Billion | ▲ +320.0% |
| 2014 | 0.13x | ₩4.99 Billion | ₩38.57 Billion | ▼ -53.7% |
| 2013 | 0.28x | ₩10.19 Billion | ₩36.41 Billion | — |